Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C20H35NO2S |
| Molecular Weight | 353.562 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCCCCCNCC(O)COC1=CC=C(SC(C)C)C=C1
InChI
InChIKey=ZAPDURRCHSKKKK-UHFFFAOYSA-N
InChI=1S/C20H35NO2S/c1-4-5-6-7-8-9-14-21-15-18(22)16-23-19-10-12-20(13-11-19)24-17(2)3/h10-13,17-18,21-22H,4-9,14-16H2,1-3H3
| Molecular Formula | C20H35NO2S |
| Molecular Weight | 353.562 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Tipropidil designed for the treatment of cerebral and peripheral vascular diseases. Tipropidil has been investigated because of its expected antihyperviscosity properties. The increase in plasma free fatty acid levels and decrease in lipolytic response were found to be dependent on the amount of Tipropidil administered. Addition of Tipropidil to the in vitro lipolysis system inhibited norepinephrine- and theophylline-induced fatty acid release in a dose-dependent manner. These results suggest a potent inhibitory action for Tipropidyl on fatty acid mobilization in rat adipose tissue.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: GO:0006629 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6278505 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6278505
Single dose - 50 mg/kg body wt
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:24:33 GMT 2025
by
admin
on
Mon Mar 31 18:24:33 GMT 2025
|
| Record UNII |
007QF56M4D
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29707
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID50867963
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
100000077262
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
4852
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
C033800
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
C84216
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
CHEMBL2111005
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
SUB11108MIG
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
70895-45-3
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
007QF56M4D
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY | |||
|
72176
Created by
admin on Mon Mar 31 18:24:33 GMT 2025 , Edited by admin on Mon Mar 31 18:24:33 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |